118 related articles for article (PubMed ID: 33252170)
1. Bis-conjugation of Bioactive Molecules to Cisplatin-like Complexes through (2,2'-Bipyridine)-4,4'-Dicarboxylic Acid with Optimal Cytotoxicity Profile Provided by the Combination Ethacrynic Acid/Flurbiprofen.
Biancalana L; Batchelor LK; Pereira SAP; Tseng PJ; Zacchini S; Pampaloni G; Saraiva LMFS; Dyson PJ; Marchetti F
Chemistry; 2020 Dec; 26(72):17525-17535. PubMed ID: 33252170
[TBL] [Abstract][Full Text] [Related]
2. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity.
Biancalana L; Kostrhunova H; Batchelor LK; Hadiji M; Degano I; Pampaloni G; Zacchini S; Dyson PJ; Brabec V; Marchetti F
Inorg Chem; 2021 Jul; 60(13):9529-9541. PubMed ID: 34156246
[TBL] [Abstract][Full Text] [Related]
3. Varying the metal to ethacrynic acid ratio in ruthenium(ii)/osmium(ii)-p-cymene conjugates.
Păunescu E; Soudani M; Clavel CM; Dyson PJ
J Inorg Biochem; 2017 Oct; 175():198-207. PubMed ID: 28779652
[TBL] [Abstract][Full Text] [Related]
4. Influence of Ligand and Nuclearity on the Cytotoxicity of Cyclometallated C^N^C Platinum(II) Complexes.
Kergreis A; Lord RM; Pike SJ
Chemistry; 2020 Nov; 26(65):14938-14946. PubMed ID: 32520417
[TBL] [Abstract][Full Text] [Related]
5. Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug.
Lee KGZ; Babak MV; Weiss A; Dyson PJ; Nowak-Sliwinska P; Montagner D; Ang WH
ChemMedChem; 2018 Jun; 13(12):1210-1217. PubMed ID: 29637702
[TBL] [Abstract][Full Text] [Related]
6. Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.
Marverti G; Cusumano M; Ligabue A; Di Pietro ML; Vainiglia PA; Ferrari A; Bergomi M; Moruzzi MS; Frassineti C
J Inorg Biochem; 2008 Apr; 102(4):699-712. PubMed ID: 18082268
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents.
Yoo J; Do Y
Dalton Trans; 2009 Jul; (25):4978-86. PubMed ID: 19662290
[TBL] [Abstract][Full Text] [Related]
8. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
[TBL] [Abstract][Full Text] [Related]
9. Anticancer ruthenium(II) tris(pyrazolyl)methane complexes with bioactive co-ligands.
Gobbo A; Pereira SAP; Biancalana L; Zacchini S; Saraiva MLMFS; Dyson PJ; Marchetti F
Dalton Trans; 2022 Nov; 51(44):17050-17063. PubMed ID: 36314260
[TBL] [Abstract][Full Text] [Related]
10. Novel 4,4'-diether-2,2'-bipyridine cisplatin analogues are more effective than cisplatin at inducing apoptosis in cancer cell lines.
Vo V; Kabuloglu-Karayusuf ZG; Carper SW; Bennett BL; Evilia C
Bioorg Med Chem; 2010 Feb; 18(3):1163-70. PubMed ID: 20074971
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Ag(I) camphor sulphonylimine complexes and assessment of their cytotoxic properties against cisplatin-resistant A2780cisR and A2780 cell lines.
Cardoso JMS; Correia I; Galvão AM; Marques F; Carvalho MFNN
J Inorg Biochem; 2017 Jan; 166():55-63. PubMed ID: 27835775
[TBL] [Abstract][Full Text] [Related]
12. Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential.
Côrte-Real L; Teixeira RG; Gírio P; Comsa E; Moreno A; Nasr R; Baubichon-Cortay H; Avecilla F; Marques F; Robalo MP; Mendes P; Ramalho JPP; Garcia MH; Falson P; Valente A
Inorg Chem; 2018 Apr; 57(8):4629-4639. PubMed ID: 29611696
[TBL] [Abstract][Full Text] [Related]
13. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
14. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH
Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296
[TBL] [Abstract][Full Text] [Related]
15. Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand.
Côrte-Real L; Karas B; Gírio P; Moreno A; Avecilla F; Marques F; Buckley BT; Cooper KR; Doherty C; Falson P; Garcia MH; Valente A
Eur J Med Chem; 2019 Feb; 163():853-863. PubMed ID: 30579125
[TBL] [Abstract][Full Text] [Related]
16. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
Farrell N; Kelland LR; Roberts JD; Van Beusichem M
Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
18. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties.
Marcon G; Carotti S; Coronnello M; Messori L; Mini E; Orioli P; Mazzei T; Cinellu MA; Minghetti G
J Med Chem; 2002 Apr; 45(8):1672-7. PubMed ID: 11931621
[TBL] [Abstract][Full Text] [Related]
19. New palladium and platinum complexes with bioactive 3,5-diacetyl-1,2,4-triazol bis(4-cyclohexyl thiosemicarbazone) ligand: chemistry, antiproliferative activity and preliminary toxicity studies.
Matesanz AI; Perles J; Souza P
Dalton Trans; 2012 Oct; 41(40):12538-47. PubMed ID: 22955178
[TBL] [Abstract][Full Text] [Related]
20. Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF7 cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorines or cisplatin.
Morrow CS; Smitherman PK; Townsend AJ
Biochem Pharmacol; 1998 Oct; 56(8):1013-21. PubMed ID: 9776312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
